Avita Medical | 1811094D - Des Atouts





Des Atouts Changement Date
Accuray USD 448.01M 8.81M 2025-12
Celltrion KRW 768.81B 9.37B 2026-03
Clinuvel Pharmaceuticals AUD 269.7M 2.05M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pacific Edge NZD 17.6M 17.06M 2026-06
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
Pharma Mar EUR 393.6M 8.34M 2026-06
Polynovo AUD 123.37M 4.04M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Qiagen NV USD 5.89B 107.14M 2026-06
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.78B 280.91M 2026-03
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Telix Pharmaceuticals AUD 1.36B 197.86M 2026-06
Tilray USD 2.1B 15.95M 2025-09
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.51B 129.02M 2026-06